ALMS

ALUMIS INC.

Pharmaceuticals · Pharmaceuticals

$190.60 sample

+3.40 (+1.82%) 1D

Market cap

$374.8B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-28

Alerts

8

Price$190.60 +4.14% 3M daily closessample

206.11180.09

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: Chief Financial Officer
Oct 05INSInsider sell: Director
Sep 28SEC8-K filed: material event
Sep 21SEC10-Q filed
Sep 11INSInsider sell: Director
Sep 04INSInsider sell: General Counsel
Aug 28INSInsider buy: Director
Aug 19INSInsider sell: General Counsel

Sign up to see the real ALMS record →

Company facts

SEC EDGAR registration

Name: ALUMIS INC.
Sector: Pharmaceuticals
Industry: Pharmaceuticals
Smart-money score: +53sample, -100 to +100
Reporting currency: USD

Who is positioning in ALMS

sample

Insiders: 11 insider transactions over 90 days, net selling, $92.3M
Congress: 4 members traded over 90 days
Institutions · 13F: 18 funds hold $4.8B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$11.8B +22.3% y/y

Q4 2024Q3 2026

Inventory$6.7B +11.4% y/y

Q4 2024Q3 2026

Accounts receivable$5.1B +7.5% y/y

Q4 2024Q3 2026

Total debt$13.9B +8.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $145.1B -10.6% 3M
Sample peer B: $243.5B +16.4% 3M
Sample peer C: $127.7B -7.5% 3M
Sample peer D: $262.4B -10.7% 3M
Sample peer E: $287.1B -5.8% 3M